In light of how dependent the US pharmaceutical industry is on China, it’s painfully obvious that Tom Cotton’s op-ed is must reading. Sen. Cotton’s op-ed highlights Vice President Biden’s pro-China bent. Sen. Cotton emphasizes his willingness to work with other Democrats on trade issues.

For instance, Sen. Cotton wrote “I’ve worked extensively with Democrats on China, with Chuck Schumer on cracking down on Chinese fentanyl trafficking, with Chris Van Hollen and numerous others on Huawei’s threat to the world’s telecommunications infrastructure. I don’t exactly hear Biden hammering on these important issues on the campaign trail. And when a few weeks ago President Trump acted to impose travel restrictions on China as a consequence of its abysmal handling of the Wuhan coronavirus, Biden was right there and ready to act as Beijing’s lawyer, slamming the policy as ‘hysterical xenophobia.'”

Now that President Trump has imposed a month-long travel ban on Europe (minus the British), where is Biden’s hysterical calls that President Trump is engaged in “hysterical xenophobia”? The answer comes in this paragraph:

Now Biden’s back on the campaign trail, and no one could be more thrilled than the Chinese Communist Party. (A Forbes headline last year summed up the situation well: “Joe Biden Is the Only Man Who Can Save China in 2020.”) Biden’s announcement of his campaign alone was enough to encourage Beijing suddenly to take a harder line on trade negotiations with the Trump administration. As Biden’s star seemed to fade, China suddenly got easier to deal with, striking a “Phase 1” deal with us in January. It’s a safe prediction that they are about to take a tougher line again. Meanwhile, Biden offers gems like these on the campaign trail. From May: China is going to eat our lunch? Come on, man. They’re not bad folks, folks. But guess what? They’re not competition for us.” And just the next month: “Our workers are literally three times as productive as workers … in Asia. So what are we worried about?”

For China Joe, stealing America’s pharmaceutical infrastructure apparently isn’t cause for worry. It isn’t just about competitiveness. It’s about putting in place a foundation where China owns something that we rely on for our public health. That makes it a national security issue. We can’t put that at risk. We’re an economic powerhouse because we’re innovators and because we figure out efficiencies all the time.

Now that he’s the prohibitive frontrunner for the Democrat nomination, it’s time to think about how a Biden administration would sell us out to the Chinese. This isn’t something we can afford to get wrong. Lives literally are at stake.

Leave a Reply